Asahi Kasei Corporate Venture Capital (AKCVC)

www.asahikaseiventures.com ; www.ak-america.com/inaction/CVC-Narrative.html

Foreign Corporate VC

Tech Verticals Preferences

AgriTech, Automotive, Bioinformatics, Biomed, Biopharmaceuticals, Cleantech, Climate Tech, Construction Tech, Consumer-Oriented Software, Decarbonization, Digital Health, Drug Delivery, Energy, Energy Tech, FoodTech, Industrial Technologies, Industry 4.0, IoT, Materials, Medical Devices, Robotics, Semiconductors, Sensors, Software Technologies, Sustainability

General Data

Established	2008
Current Active Portfolio Companies:	1

DESCRIPTION

Asahi Kasei Corporate Venture Capital is focused on investing in innovative global companies in areas of strategic importance to Asahi Kasei. Our primary mission is to create new long-term business opportunities for Asahi Kasei. Our team, based in Menlo Park, the Boston area, Düsseldorf and Shanghai, consists of senior professionals with backgrounds in R&D, start up operations and venture capital.
Asahi Kasei invests across all stages. Our initial investment size can range from several hundred thousand dollars up to several million, depending on the opportunity. Given the right situation, Asahi Kasei can lead investments.

AFFILIATION

Account ID	Affiliation Type	Name	Parent Name	Status
		Asahi Kasei Corp.
E8A7331A-83FF-ED11-B811-00505695CD29	Investment Arm	Asahi Kasei Corporate Venture Capital (AKCVC)	Asahi Kasei Corp.
	Subsidiary	ZOLL Medical Corp. (an Asahi Kasei company)	Asahi Kasei Corp.
A8053D0D-3A14-EA11-8107-0050569A1018	R&D Center	Zoll Medical Israel Ltd. (an Asahi Kasei company)	ZOLL Medical Corp. (an Asahi Kasei company)

CONTACT INFO

Expand / Collapse All

Main Address: Tokyo, Japan

City	Tokyo
Country	Japan

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Menlo Park, United States

Address	4400 Bohannon Dr., Suite 240
City	Menlo Park
State/Province	CA
Country	United States
Zip	94025

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Dr. Takashi Morishita	General Manager

Investment Data

Capital Remarks

Initial investment size can range from several hundred thousand dollars up to several millions.

Preferences

Type of Financing	Equity
Stage Preferences	Initial Revenues,R&D,Revenue Growth,Seed

SECTOR SEGMENTATION (By Number Of Companies)

Medical Devices

100%

	PORTFOLIO COMPANIES

Current Portfolio Companies (1)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

Laminate Medical

R&D Grant	01/06/2020	N/A	N/A
Third Round - Extended	24/10/2019	N/A	N/A
Third Round	31/01/2019	N/A	$12m

Exits (1)

Company Name		Exit Type	Date Announced	Amount	Remarks
abC Defghij		Acquired	01/03/2023	abCDe

Historic Portfolio (2)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

Atox Bio

Ceased to Operate

Biomed

Fifth Round

04/12/2017

N/A

$30m

Castor

Suspendeed Operations

Ent. SW

First Round

16/05/2023

N/A

Last Updated:	abCDe
IVC Number:	abCDe